Skip to main content

Table 4 The summary of subgroup analyses results

From: Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials

Subgroup analysis

Studies (n)

Participants (n)

RR (95% CI)

I 2(%)

P heterogeneity

P value

Prospective

5

826

0.63 (0.48-0.83)

0.00

0.7

0.001

Consecutive

4

624

0.56 (0.37-0.83)

0.00

0.7

0.005

Follow-up

6

924

0.66 (0.51-0.85)

0.00

0.8

0.002

  1. CI, confidence interval; n, number of studies; RR, risk ratio